CRVS
Corvus Pharmaceuticals, Inc. · Healthcare
Novo Holdings A/s sold $6.1M of Corvus Pharmaceuticals, Inc.
10% owner
Sold$6,077,845
$4.07Price
1,492,956Shares
−34%Stake
What CRVS did after the filing
Prices for CRVS after this filing aren't in yet.
Traded Tue, Jul 23. Filed Thu, Jul 25, 7:21 PM ET, after the close. Not investment advice.